Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 14, 2017; 23(38): 6983-6994
Published online Oct 14, 2017. doi: 10.3748/wjg.v23.i38.6983
Figure 4
Figure 4 The changes of hepatic function and hepatic pathology before and after treatment with VSL#3 or fecal microbiota transplantation. A-E: Serological parameter examinations suggested improved hepatic function. Blood samples were collected from the indicated groups at the described time points and analyzed using an automatic biochemistry analyzer; F: Rats treated with FMT showed attenuated liver damage (arrow); J-L: FMT administration decreased CCl4-induced liver necrosis in rats. I: Following VSL#3 treatment, liver dikaryocytes (arrow) were visible; K, L: Following FMT, liver cells with red nucleolus were visible (arrow). FMT: Fecal microbiota transplantation.